PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
244.00
+6.00 (2.52%)
Jun 19, 2026, 4:00 PM WIB
IDX:DGNS Market Cap
IDX:DGNS has a market cap or net worth of 305 billion as of June 18, 2026. Its market cap has increased by 49.69% in one year.
Market Cap
305.00B
Enterprise Value
375.52B
Revenue
171.06B
Ranking
n/a
PE Ratio
91.15
Stock Price
244.00
Market Cap Chart
Since January 15, 2021, IDX:DGNS's market cap has decreased from 337.50B to 305.00B, a decrease of -9.63%. That is a compound annual growth rate of -1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 305.00B | 32.61% |
| Dec 30, 2025 | 230.00B | -5.64% |
| Dec 30, 2024 | 243.75B | -20.73% |
| Dec 29, 2023 | 307.50B | 0.82% |
| Dec 30, 2022 | 305.00B | -67.25% |
| Dec 30, 2021 | 931.25B | 175.93% |
| Jan 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 134.63T |
| PT Kalbe Farma Tbk. | 31.67T |
| PT Siloam International Hospitals Tbk | 28.18T |
| PT Mitra Keluarga Karyasehat Tbk | 22.25T |
| PT Diastika Biotekindo Tbk | 538.85B |
| PT Indofarma Tbk | 390.51B |
| PT Maja Agung Latexindo Tbk | 386.40B |
| PT Ikapharmindo Putramas Tbk | 320.09B |